We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension (PILGRIM)

This study is currently recruiting participants.
Verified February 2016 by Wook-Jin Chung, Gachon University Gil Medical Center
Sponsor:
ClinicalTrials.gov Identifier:
NCT01054105
First Posted: January 22, 2010
Last Update Posted: February 11, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Seoul National University Hospital
Seoul National University Bundang Hospital
The Catholic University of Korea
Bayer
Information provided by (Responsible Party):
Wook-Jin Chung, Gachon University Gil Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)